Nello Mainolfi Insider Trading $KYMR Kymera Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nello Mainolfi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nello Mainolfi. Nello Mainolfi is Chief Executive Officer in Kymera Therapeutics, Inc. ($KYMR) and President and CEO in Kymera Therapeutics, Inc. ($KYMR).
Nello Mainolfi in Kymera Therapeutics, Inc.
Trading Symbol: KYMRIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Nello Mainolfi: Chief Executive Officer, President and CEO
Holdings: 424,923 shares
Latest Transaction: Jun 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nello Mainolfi in Kymera Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 5,752 | 11,964 | 197,734 | |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 270 | 562 | 203,486 | |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 12,724 | 26,466 | 203,756 | |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 50.02 | 5,752 | 287,721 | 412,199 | 418 K to 412.2 K (-1.38 %) |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 5,752 | 11,964 | 417,951 | 412.2 K to 418 K (+1.40 %) |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 50.00 | 270 | 13,500 | 412,199 | 412.5 K to 412.2 K (-0.07 %) |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 270 | 562 | 412,469 | 412.2 K to 412.5 K (+0.07 %) |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 50.14 | 12,724 | 638,040 | 412,199 | 424.9 K to 412.2 K (-2.99 %) |
Jun 09 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 12,724 | 26,466 | 424,923 | 412.2 K to 424.9 K (+3.09 %) |
May 14 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 8,245 | 17,150 | 216,480 | |
May 14 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 50.05 | 8,245 | 412,677 | 397,199 | 405.4 K to 397.2 K (-2.03 %) |
May 14 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 8,245 | 17,150 | 405,444 | 397.2 K to 405.4 K (+2.08 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 2,768 | 5,757 | 224,725 | |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 680 | 1,414 | 227,493 | |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 10,959 | 22,795 | 228,173 | |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 40.18 | 2,768 | 111,229 | 397,199 | 400 K to 397.2 K (-0.69 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 2,768 | 5,757 | 399,967 | 397.2 K to 400 K (+0.70 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 40.01 | 680 | 27,208 | 397,199 | 397.9 K to 397.2 K (-0.17 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 680 | 1,414 | 397,879 | 397.2 K to 397.9 K (+0.17 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 40.26 | 10,959 | 441,182 | 397,199 | 408.2 K to 397.2 K (-2.68 %) |
Apr 26 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 10,959 | 22,795 | 408,158 | 397.2 K to 408.2 K (+2.76 %) |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 6,000 | 12,480 | 151,424 | |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 653 | 1,358 | 239,132 | |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 4,940 | 10,275 | 239,785 | |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 6,000 | 12,480 | 397,199 | 391.2 K to 397.2 K (+1.53 %) |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 40.00 | 653 | 26,121 | 391,199 | 391.9 K to 391.2 K (-0.17 %) |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 653 | 1,358 | 391,852 | 391.2 K to 391.9 K (+0.17 %) |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 40.29 | 4,940 | 199,039 | 391,199 | 396.1 K to 391.2 K (-1.25 %) |
Apr 19 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 4,940 | 10,275 | 396,139 | 391.2 K to 396.1 K (+1.26 %) |
Apr 13 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 15,000 | 31,200 | 157,424 | |
Apr 13 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 15,000 | 31,200 | 391,199 | 376.2 K to 391.2 K (+3.99 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 15,267 | 31,755 | 244,725 | |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 22,794 | 47,412 | 259,992 | |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Option Exercise | M | 2.08 | 9,939 | 20,673 | 282,786 | |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 33.32 | 4,905 | 163,414 | 376,199 | 381.1 K to 376.2 K (-1.29 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 32.29 | 10,362 | 334,566 | 381,104 | 391.5 K to 381.1 K (-2.65 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 15,267 | 31,755 | 391,466 | 376.2 K to 391.5 K (+4.06 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 34.19 | 3,742 | 127,923 | 376,199 | 379.9 K to 376.2 K (-0.98 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 33.58 | 19,052 | 639,827 | 379,941 | 399 K to 379.9 K (-4.78 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 22,794 | 47,412 | 398,993 | 376.2 K to 399 K (+6.06 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 35.62 | 2,323 | 82,748 | 376,199 | 378.5 K to 376.2 K (-0.61 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Sell | S | 34.81 | 7,616 | 265,084 | 378,522 | 386.1 K to 378.5 K (-1.97 %) |
Apr 12 2021 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | Chief Executive Off ... | Buy | M | 2.08 | 9,939 | 20,673 | 386,138 | 376.2 K to 386.1 K (+2.64 %) |
Aug 21 2020 | KYMR | Kymera Therapeutic ... | Mainolfi Nello | President and CEO | Option Exercise | A | 20.00 | 125,399 | 2,507,980 | 125,399 |
Page: 1